High KIFC1 expression is associated with poor prognosis in prostate cancer.
Laurie G KosteckaAthen OlseenKiChang KangGonzalo TorgaKenneth J PientaSarah R AmendPublished in: Medical oncology (Northwood, London, England) (2021)
Kinesins play important roles in the progression and development of cancer. Kinesin family member C1 (KIFC1), a minus end-directed motor protein, is a novel Kinesin involved in the clustering of excess centrosomes found in cancer cells. Recently KIFC1 has shown to play a role in the progression of many different cancers, however, the involvement of KIFC1 in the progression of prostate cancer (PCa) is still not well understood. This study investigated the expression and clinical significance of KIFC1 in PCa by utilizing multiple publicly available datasets to analyze KIFC1 expression in patient samples. High KIFC1 expression was found to be associated with high Gleason score, high tumor stage, metastatic lesions, high ploidy levels, and lower recurrence-free survival. These results reveal that high KIFC1 levels are associated with a poor prognosis for PCa patients and could act as a prognostic indicator for PCa patients as well.
Keyphrases
- poor prognosis
- prostate cancer
- long non coding rna
- free survival
- ejection fraction
- radical prostatectomy
- newly diagnosed
- end stage renal disease
- small cell lung cancer
- gene expression
- prognostic factors
- binding protein
- single cell
- small molecule
- young adults
- patient reported outcomes
- genome wide
- squamous cell
- amino acid